Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

Ai-Lan Nguyen; Eva Kubala Havrdova; Dana Horakova; Guillermo Izquierdo; Tomas Kalincik; Anneke van der Walt; Murat Terzi; Raed Alroughani; Pierre Duquette; Marc Girard; Alexandre Prat; Cavit Boz; Patrizia Sola; Diana Ferrara; Alessandra Lugaresi; Jeannette Lechner-Scott; Michael Barnett; Francois Grand'Maison; Pierre Grammond; Cristina Ramo-Tello; Recai Turkoglu; Pamela McCombe; Eugenio Pucci; Maria Trojano; Franco Granella; Daniele Spitaleri; Vincent Van Pesch; Aysun Soysal; Celia Oreja-Guevara; Freek Verheul; Steve Vucic; Suzanne Hodgkinson; Mark Slee; Radek Ampapa; Julie Prevost; Jose Luis Sanchez Menoyo; Olga Skibina; Claudio Solaro; Javier Olascoaga; Cameron Shaw; Klaus Gregaard Madsen; Kerisha Naidoo; Robert Hyde; Helmut Butzkueven; Vilija Jokubaitis

Journal article

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

Ai-Lan Nguyen, Eva Kubala Havrdova, Dana Horakova, Guillermo Izquierdo, Tomas Kalincik, Anneke van der Walt, Murat Terzi, Raed Alroughani, Pierre Duquette, Marc Girard, Alexandre Prat, Cavit Boz, Patrizia Sola, Diana Ferrara, Alessandra Lugaresi, Jeannette Lechner-Scott, Michael Barnett, Francois Grand'Maison, Pierre Grammond, Cristina Ramo-Tello Show all

Multiple Sclerosis and Related Disorders | ELSEVIER SCI LTD | Published : 2019

DOI: 10.1016/j.msard.2019.01.003

University of Melbourne Researchers

Melanie Bahlo Author Mathematics and Statistics

Vilija Jokubaitis Author Medicine - Royal Melbourne Hospital

Helmut Butzkueven Author Medicine - Royal Melbourne Hospital

Tomas Kalincik Author Medicine - Royal Melbourne Hospital

Anneke van der Walt Author Medicine - Royal Melbourne Hospital

Grants

Awarded by National Health and Medical Research Council of Australia centre for research excellence grant

Funding Acknowledgements

This study was financially supported by a National Health and Medical Research Council of Australia centre for research excellence grant [1001216]. The MSBase Foundation is a not-for-profit organisation that receives support from Biogen, Merck, Novartis, Roche and Sanofi-Genzyme. The study was conducted separately and apart from the guidance of the sponsors.